Stock comparison
ResMed
SANUWAVE Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
RMD
ResMed
Market cap
$29.57B
Sector
Healthcare
SNWV
SANUWAVE Health
Market cap
$137.85M
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | RMD | SNWV | Winner |
|---|---|---|---|
| Warren Buffett | 64C | 38D | RMD |
| Benjamin Graham | 67B | 50C | RMD |
| Philip Fisher | 67B | 54C | RMD |
| Peter Lynch | 50C | 100A | SNWV |
| Joel Greenblatt | 39D | 57C | SNWV |
| Charlie Munger | 61C | 51C | RMD |
| Terry Smith | 65B | 44D | RMD |
Side-by-side metrics
| Metric | RMD | SNWV |
|---|---|---|
| Market cap | $29.57B | $137.85M |
| P/E (TTM) | 19.6x | 8.6x |
| EV/EBIT | 17.1x | 27.1x |
| ROIC (TTM) | 19.63% | 11.43% |
| Gross margin | 61.69% | 74.75% |
| Net margin | 27.44% | 36.21% |
| Revenue CAGR 5y | 12.64% | 35.65% |
| EPS CAGR 5y | 30.73% | - |
| Debt / Equity | 0.1x | 3.9x |
| Dividend yield | 1.14% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RMD leads on
- Dividend yield1.14%vs 0.0%+100%
- Market cap$29.57Bvs $137.85M+100%
- Debt / Equity0.1xvs 3.9x+97%
- ROIC (TTM)19.63%vs 11.43%+42%
SNWV leads on
- Revenue CAGR 5y35.65%vs 12.64%+65%
- P/E (TTM)8.6xvs 19.6x+56%
- Net margin36.21%vs 27.44%+24%
- Gross margin74.75%vs 61.69%+17%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.